Predictors of Non-response and Loss of Response in IBD Patients Treated With Anti-TNF
This study is currently recruiting participants.
Verified July 2012 by Evangelismos Hospital
Information provided by (Responsible Party):
Nikos Viazis, Evangelismos Hospital
First received: May 22, 2012
Last updated: July 26, 2012
Last verified: July 2012
The aim of our study is to prospectively identify, at diagnosis, factors predictive of non-response or loss of response in patients with inflammatory bowel disease treated with anti-TNF.
Inflammatory Bowel Disease
||Observational Model: Case-Crossover
Time Perspective: Prospective
||Predictors of Non-response and Loss of Response in IBD Patients Treated With Anti-TNF.
Biospecimen Retention: Samples With DNA
Whole blood Serum Bowel mucosal tissue
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||July 2012 (Final data collection date for primary outcome measure)
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
IBD patients treated with anti-TNF that need dose escalation.
- Active Crohn's luminal ileitis, colitis or ileocolitis necessitating therapy with anti-TNF, according to the physician's judgment, based on the current ECCO guidelines.
- Corticosteroid resistant or corticosteroid dependent ulcerative colitis, necessitating therapy with anti-TNF, according to the physician's judgment, based on the current ECCO guidelines.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01605188
|Athens, Greece |
|Contact: Nikos Viazis, Consultant 0036977617000 firstname.lastname@example.org |
|Contact: Theodoros Koukouratos, Senior email@example.com |
|Principal Investigator: Nikos Viazis |
|Sub-Investigator: Theodoros Koukouratos |
No publications provided
||Nikos Viazis, Consaltant Gastroenterologist, Evangelismos Hospital
History of Changes
|Other Study ID Numbers:
|Study First Received:
||May 22, 2012
||July 26, 2012
||Greece: Ethics Committee
Greece: Ministry of Health and Welfare
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on December 09, 2013
Inflammatory Bowel Diseases
Digestive System Diseases